Antibiotic-treated infections in intensive care patients in the UK

Anaesthesia

Volumn 59, Issue 9, 2004, Pages 885-890

  Cuthbertson, Brian H ^a   Thompson, M ^a   Sherry, A ^b   Wright, M M ^c   Bellingan, G J ^d  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b ST THOMAS HOSPITAL   (United Kingdom)

^c JAMES PAGET UNIVERSITY HOSPITAL   (United Kingdom)

^d UNIVERSITY COLLEGE HOSPITAL   (United Kingdom)

Author keywords

Antibiotics; Infection; Intensive care

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN; MACROLIDE; METRONIDAZOLE; ANTIINFECTIVE AGENT;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ARTICLE; CATHETER INFECTION; CLINICAL PRACTICE; CLINICAL TRIAL; COMMUNICABLE DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE SEVERITY; FEMALE; GRAM NEGATIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; INFECTION CONTROL; INTENSIVE CARE UNIT; LUNG INFECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRACTICE GUIDELINE; SEPSIS; SEPTIC SHOCK; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; UNITED KINGDOM; WOUND INFECTION; BACTERIAL INFECTION; CROSS INFECTION; DRUG ADMINISTRATION; INTENSIVE CARE; MEDICAL AUDIT; METHODOLOGY; MIDDLE AGED; STATISTICS;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; COMMUNITY-ACQUIRED INFECTIONS; CROSS INFECTION; DRUG ADMINISTRATION SCHEDULE; FEMALE; GREAT BRITAIN; GUIDELINE ADHERENCE; HUMANS; INTENSIVE CARE; MALE; MEDICAL AUDIT; MIDDLE AGED; PHYSICIAN'S PRACTICE PATTERNS; PRACTICE GUIDELINES;

EID: 4444258298     PISSN: 00032409     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2044.2004.03742.x     Document Type: Article

References (21)

1. Spencer KC. Epidemiology of infection in ICUs. Intensive Care Medicine 1994; 20: S2-6.
2. Vincent JL, Bihari DJ, Suter PM, et al. The prevalence of nosocomial infection in intensive care units in Europe. Results of the European Prevalence of Infection in Intensive Care (EPIC) Study. EPIC International Advisory Committee. Journal of American Medical Association 1995; 274: 639-44.
3. Kollef MH. Optimising antibiotic therapy in the intensive care. Critical Care 2001; 5: 189-95.
4. Walther SM, Erlandsson M, Burman LG, et al. Antibiotic prescription practices, consumption and bacterial resistance in a cross section of Swedish intensive care units. Acta Anaesthesiologica Scandinavica 2002; 46: 1075-81.
5. Hails J, Kwaku F, Wilson AP, Bellingan GJ, Singer M. Large variation in MRSA policies, procedures and prevalence in English intensive care units. A questionnaire analysis. Intensive Care Medicine 2003; 29: 481-3.
6. Rello J, Ausina V, Ricart M, Castella J, Prats G. Impact of previous antimicrobial therapy on the etiology and outcome of ventilator-associated pneumonia. Chest 1993; 104: 1230-5.
7. Goldmann DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of antimicrobial-resistant microorganisms in hospitals. A challenge to hospital leadership. Journal of American Medical Association 1996; 275: 234-40.
8. Hubmayr RD. Statement of the 4th International Consensus Conference in Critical Care on ICU-acquired pneumonia - Chicago, Illinois May 2002. Intensive Care Medicine 2002; 28: 1521-36.
9. Mandell LA, Marrie TJ, Grossman RF, Chow AW, Hyland RH. Canadian guidelines for the initial management of community-acquired pneumonia: an evidence-based update by the Canadian Infectious Diseases Society and the Canadian Thoracic Society. The Canadian Community-Acquired Pneumonia Working Group. Clinical Injectious Disease 2000; 31: 383-421.
10. Niederman MS, Mandell LA, Anzueto A, et al. American Thoracic Society Guidelines for the Management of Adults with Community-acquired Pneumonia Diagnosis, Assessment of Severity, Antimicrobial Therapy, and Prevention. American Journal of Respiratory and Critical Care Medicine 2001; 163: 1730-54.
11. Singh N, Rogers P, Atwood CW, Wagener MM, Yu VL. Short-course empiric antibiotic therapy for patients with pulmonary infiltrates in the intensive care unit. A proposed solution for indiscriminate antibiotic prescription. American Journal of Respiratory and Critical Care Medicine 2000; 162: 505-51.
12. Kollef MH, Ward S, Sherman G, et al. Inadequate treatment of nosocomial infections is associated with certain empiric antibiotic choices. Critical Care Medicine 2000; 28: 3456-64.
13. Meehan TP, Fine MJ, Krumholz HM, et al. Quality of care, process, and outcomes in elderly patients with pneumonia. Journal of American Medical Association 1997; 278: 2080-4.
14. Diaz E, Rello J. Top ten list in antibiotic policy in ICU. Chest 2002; 122: 712-4.
15. Gruson D, Hilbert G, Vargas F, et al. Rotation and restricted use of antibiotics in a medical intensive care unit. Impact on the incidence of ventilator-associated pneumonia caused by antibiotic-resistant gram-negative bacteria. Journal of American Medical Association 2000; 162: 837-43.
16. Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101: 1644-55.
17. Anonymous. CDC definitions for nosocomial infections. American Review of Respiratory Disease 1989; 139: 1058-9.
18. Ibrahim EH, Ward S, Sherman G, Schaiff R, Fraser VJ, Kollef MH. Experience with a clinical guideline for the treatment of ventilator-associated pneumonia. Critical Care Medicine 2001; 29: 1109-15.
19. Bergmans DC, Bonten MJ, Gaillard CA, et al. Indications for antibiotics in use in ICU patients: a one year prospective surveillance. Journal of Antimicrobial Chemotherapy 1997; 39: 527-35.
20. Meduri GU. Ventilator-associated pneumonia in patients with respiratory failure. A diagnostic approach. Chest 1990; 97: 1208-19.
21. George DL, Falk PS, Wunderink RG, et al. Epidemiology of ventilator-acquired pneumonia based on protected bronchoscopic sampling. American Journal of Respiratory and Critical Care Medicine 1998; 158: 1839-47.